Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Nephrology (kidneys)

  • 1
    News

    Impaired kidney function no problem for dabigatran reversal

    April 23, 2018

    ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.

  • 1
    News

    Sodium bicarbonate and acetylcysteine for prevention of contrast-related morbidity and mortality in CKD patients

    April 20, 2018

    Clinical question: Do either intravenous sodium bicarbonate or oral acetylcysteine prevent renal morbidity and mortality in patients with chronic kidney disease (CKD) undergoing angiography?.

  • 1
    News

    How should electrolyte abnormalities be managed in patients with chronic kidney disease?

    February 27, 2018

    Electrolyte abnormalities in CKD are numerous and have multiple adverse clinical outcomes.

  • 1
    News

    Contrast nephropathy after computed tomography

    January 26, 2018

    Clinical question: Do rates of acute kidney injury (AKI), renal replacement therapy (RRT), or mortality differ between adults receiving contrast-enhanced computed tomography (CT) versus those receiving noncontrast CT?

  • 1
    News

    Acute kidney injury linked with doubled inpatient VTEs

    December 8, 2017

    TORONTO – Which comes first: the acute kidney injury or the venous thromboembolism?

  • 1
    News

    Intense urine output monitoring beneficial in ICU

    December 2, 2017

    Patients who underwent intensive urine output monitoring received less fluid in their first 24 hours than did those who received less intensive monitoring.

  • 1
    News

    VIDEO: Balanced crystalloids protect kidney better than saline

    November 1, 2017

    TORONTO – Vanderbilt University Medical Center is transitioning from primarily using saline to balanced crystalloid IV fluids to prevent adverse renal events in hospitalized patients.

  • 1
    News

    Carvedilol fails to reduce variceal bleeds in acute-on-chronic liver failure

    October 24, 2017

    Some improvement seen at 28 days in acute kidney injury, sepsis.

  • 1
    News

    Oral anticoagulation ‘reasonable’ in advanced kidney disease with A-fib

    October 5, 2017

    Reduced stroke risk, no increase in bleeding in atrial fibrillation and advanced chronic kidney disease.

  • 1
    News

    FDA approves Vabomere for complicated UTI in adults

    August 31, 2017

    The new drug, administered by intravenous infusion, is expected to be available before the end of the year.

Previous1 … 6 7 8 9Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences